Q32 BIO INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.59 USD | -0.70% |
|
-8.67% | +137.21% |
| 11/04 | Oppenheimer Initiates Coverage on Q32 Bio With Outperform Rating, $50 Price Target | MT |
| 03/04 | Q32 Bio Inc. Appoints Lee Kalowski as Chief Financial Officer | CI |
Chart calendar Q32 Bio Inc.
36f2390.xr3Xyu8kkPJXykAL8SA_9AifQ6ObhCA_cQIIyfq4KzM.gPCjjKds0bQjvDdRx0Z7rl_VeufQ83daBWhG-bfrHmTwxYilwkjTnAOEFQ~f2f8924ceafcf1314ae74983bb20a31e
Upcoming events on Q32 Bio Inc.
No events available
Past events on Q32 Bio Inc.
| 15/11/2023 03:03 am | Q3 2023 Earnings Release |
| 15/08/2023 01:35 am | Q2 2023 Earnings Release |
| 28/07/2023 02:00 am | Business Update Call |
| 14/06/2023 | Annual General Meeting |
| 25/05/2023 | World Orphan Drug Congress |
| 20/05/2023 12:30 am | American Society of Gene Cell Therapy Meeting - Abstract # 1312 |
| 20/05/2023 12:30 am | American Society of Gene Cell Therapy Meeting - Abstract # 1497 |
| 20/05/2023 12:30 am | American Society of Gene Cell Therapy Meeting - Abstract # 1355 |
| 19/05/2023 12:30 am | American Society of Gene & Cell Therapy Meeting - Abstract # 989 |
| 18/05/2023 12:30 am | American Society of Gene Cell Therapy Meeting - Abstract # 376 |
| 18/05/2023 12:30 am | American Society of Gene Cell Therapy Meeting - Abstract # 386 |
| 12/05/2023 01:35 am | Q1 2023 Earnings Release |
| 17/03/2023 10:00 pm | ACMG Clinical Genetics Meeting |
| 16/03/2023 10:00 pm | ACMG Clinical Genetics Meeting |
| 14/03/2023 | ACMG Clinical Genetics Meeting |
| 12/03/2023 01:00 am | Project Alive Hunter Syndrome Community Conference |
| 10/03/2023 02:35 am | Q4 2022 Earnings Release |
| 08/03/2023 09:00 pm | Cowen Health Care Conference - Panel |
| 16/11/2022 02:40 am | Stifel Healthcare Conference |
| 11/11/2022 02:37 am | Q3 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2023 | 2024 |
|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -49,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -51,1 |
|
Net income Million USD | Released Forecast Spread | -53,7 | -51,1 |
|
EPS USD | Released Forecast Spread | -7,41 | -4,37 |
| Announcement Date | 27/03/24 | - |
Quarterly results
| Fiscal Period | December | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -11,9 | -12,2 | -12,5 | -12,8 | -13,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -14,9 | -11,7 | -12,1 | -12,4 | -13,7 |
|
Net income Million USD | Released Forecast Spread | -14,9 | -11,7 | -12,1 | -12,4 | -13,7 |
|
EPS USD | Released Forecast Spread | -1,42 | -0,98 | -1,01 | -1,04 | -0,80 |
| Announcement Date | - | - | - | - | - |
More events
Past sector events for Q32 Bio Inc.
| 03/05/2024 01:35 am | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | ZYMEWORKS INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:32 am | ARDELYX, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:31 am | LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:31 am | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 03/05/2024 01:30 am | ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release |
| 02/05/2024 08:30 pm | GENMAB A/S: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | GERON CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | BICYCLE THERAPEUTICS PLC: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- QTTB Stock
- Calendar Q32 Bio Inc.
